Epigenesis Pharmaceuticals is committed to developing inhaled respiratory medicines that are safe, effective and improve the health and quality of life in patients with asthma, obstructive pulmonary disease (COPD) and other respiratory diseases. Our novel discovery methods and development approach combined with our expertise in respiratory medicine and respiratory therapeutics allows us to accelerate the drug development process.